Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · IEX Real-Time Price · USD
44.57
-0.54 (-1.20%)
Apr 24, 2024, 2:35 PM EDT - Market open

Ultragenyx Pharmaceutical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Cash & Equivalents
213.58132.94307.58713.53433.58113.43100.49164.6195.8525.07
Upgrade
Short-Term Investments
363.63614.82432.61488.01321.65346.27134.01219.03343.43163.16
Upgrade
Cash & Cash Equivalents
577.21747.76740.21,202755.23459.71234.49383.64439.28188.23
Upgrade
Cash Growth
-22.81%1.02%-38.40%59.09%64.29%96.04%-38.88%-12.67%133.37%249.69%
Upgrade
Receivables
73.3940.4528.4323.0932.8412.745.17000
Upgrade
Inventory
33.9726.7716.2313.0511.557.070.76000
Upgrade
Other Current Assets
47.6268.9371.7557.6351.442.8629.1618.0610.935.19
Upgrade
Total Current Assets
732.18883.9856.61,295851.02522.37269.58401.7450.21193.42
Upgrade
Property, Plant & Equipment
290.57259.73176.18114.0474.6820.0521.8417.067.373.03
Upgrade
Long-Term Investments
199.9148.97293.86165.8832.9309.98117.9699.260
Upgrade
Goodwill and Intangibles
210.68204.51175.19175.52173.41173.63185.95000
Upgrade
Other Long-Term Assets
57.6948.3420.568.813.473.513.413.912.731.52
Upgrade
Total Long-Term Assets
758.83661.55665.79464.25284.48197.19221.17138.93109.364.55
Upgrade
Total Assets
1,4911,5451,5221,7601,135719.56490.75540.63559.57197.97
Upgrade
Accounts Payable
42.1143.2717.1412.9212.8712.288.895.362.944.86
Upgrade
Deferred Revenue
01.489.0866.57000000
Upgrade
Current Debt
12.611.7811.078.987.2400000
Upgrade
Other Current Liabilities
225.73204.68144.09101.1483.1962.4562.1354.924.987.66
Upgrade
Total Current Liabilities
280.44261.21181.37189.61103.374.7371.0160.2627.9212.52
Upgrade
Long-Term Debt
30.5719.8130.939.2529.7600000
Upgrade
Other Long-Term Liabilities
904.59911.93387.56376.32348.6835.9336.296.390.560.51
Upgrade
Total Long-Term Liabilities
935.16931.74418.47415.57378.4335.9336.296.390.560.51
Upgrade
Total Liabilities
1,2161,193599.84605.18481.73110.65107.366.6528.4813.02
Upgrade
Total Debt
43.1731.5941.9748.2336.9900000
Upgrade
Debt Growth
36.64%-24.72%-12.97%30.37%------
Upgrade
Retained Earnings
-3,387.66-2,781.02-2,073.6-1,619.58-1,433.01-1,030.28-832.67-530.53-284.66-139.04
Upgrade
Comprehensive Income
0.65-6.57-1.40.69-0.15-0.63-5.680.91-0.87-0.17
Upgrade
Shareholders' Equity
275.41352.49922.561,154653.76608.91383.45473.97531.09184.95
Upgrade
Net Cash / Debt
534.04716.17698.231,153718.24459.71234.49383.64439.28188.23
Upgrade
Net Cash / Debt Growth
-25.43%2.57%-39.46%60.57%56.24%96.04%-38.88%-12.67%133.37%249.69%
Upgrade
Net Cash Per Share
7.2610.2410.3018.9512.699.245.529.6911.946.55
Upgrade
Working Capital
451.75622.69675.241,106747.72447.64198.57341.44422.29180.9
Upgrade
Book Value Per Share
3.755.0413.6118.9711.5512.239.0311.9714.446.43
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).